Stockscreener 앱 받기
75.01
0.32%
-0.24
전일 마감가:
$75.25
열려 있는:
$77.03
하루 거래량:
2.00M
Relative Volume:
2.12
시가총액:
$11.92B
수익:
$1.17B
순이익/손실:
$150.71M
주가수익비율:
79.80
EPS:
0.94
순현금흐름:
$245.03M
1주 성능:
+3.09%
1개월 성능:
+1.02%
6개월 성능:
-4.35%
1년 성능:
+11.34%
1일 변동 폭
$73.44
$77.03
1주일 범위
$70.88
$79.28
52주 변동 폭
$61.16
$85.57
바이오-테크네 Stock (TECH) Company Profile
명칭
Bio Techne Corp
전화
(612) 379-8854
주소
614 MCKINLEY PL N E, MINNEAPOLIS, MN
TECH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
75.01 | 11.92B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
481.16 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.07 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
657.97 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
278.25 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
119.94 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
바이오-테크네 Stock (TECH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-08 | 개시 | Scotiabank | Sector Outperform |
| 2024-02-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-08-28 | 개시 | William Blair | Outperform |
| 2023-01-10 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | 업그레이드 | Stifel | Hold → Buy |
| 2021-01-25 | 재확인 | The Benchmark Company | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-07-15 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-14 | 개시 | The Benchmark Company | Buy |
| 2020-01-08 | 재개 | Stephens | Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-02 | 업그레이드 | Janney | Neutral → Buy |
| 2019-01-14 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-17 | 개시 | Goldman | Neutral |
| 2018-06-15 | 개시 | Argus | Buy |
| 2017-07-13 | 개시 | Wells Fargo | Market Perform |
| 2017-02-09 | 개시 | Citigroup | Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2013-09-20 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
모두보기
바이오-테크네 주식(TECH)의 최신 뉴스
Trust Point Inc. Increases Stake in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Conestoga Capital Advisors LLC Buys 5,025 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
There is no doubt that Bio-Techne Corp (TECH) ticks all the boxes. - SETE News
Bio-Techne Corporation (NASDAQ:TECH) Q2 2025 Earnings Call Transcript - Insider Monkey
Bio-Techne Corp (TECH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Bio-Techne (NASDAQ:TECH) Shares Gap Up After Dividend Announcement - Defense World
Bio-Techne Tops Q2 Earnings & Revenue Estimates, Stock Up in Premarket - MSN
Earnings call transcript: Bio-Techne beats Q2 2024 forecasts, stock surges By Investing.com - Investing.com South Africa
Earnings call transcript: Bio-Techne beats Q2 2024 forecasts, stock surges - Investing.com
Bio-Techne Q2 25 Earnings Conference Call At 9:00 AM ET - Nasdaq
Bio-Techne (NASDAQ:TECH) Surprises With Strong Q4, Stock Soars By Stock Story - Investing.com Canada
Bio-Techne earnings beat by $0.03, revenue topped estimates - Investing.com
Bio-Techne Appoints New Board Member and Reports Revenue Growth - TipRanks
Bio-Techne Corp Q2 FY2025 Earnings: Revenue Hits $297M, Adjusted EPS at $0.42, Surpassing Estimates - GuruFocus.com
Bio-Techne (NASDAQ:TECH) Surprises With Strong Q4, Stock Soars - Yahoo Finance
Bio-Techne Delivers Massive Earnings Beat: Cell Therapy Growth Drives Record Quarter - StockTitan
Bio-Techne Declares Dividend - Yahoo Finance
The Zacks Analyst Blog Highlights Boston Scientific, Hologic, BioTechne, STERIS And Align - Barchart
The Zacks Analyst Blog Highlights Boston Scientific, Hologic, BioTechne, STERIS and Align - Yahoo Finance
TECH (Bio-Techne) Revenue : $1,172 Mil (TTM As of Sep. 2024) - GuruFocus.com
Bio-Techne adds Dr. Amy E. Herr to its Board of Directors - Investing.com
UC Berkeley's Proteomics Pioneer and Zephyrus Founder Joins Bio-Techne's Board - StockTitan
Bio-Techne Co. (NASDAQ:TECH) Position Cut by Pacer Advisors Inc. - Defense World
How to Take Advantage of moves in (TECH) - news.stocktradersdaily.com
Kim Kelderman Sells 13,392 Shares of Bio-Techne Co. (NASDAQ:TECH) Stock - MarketBeat
SG Americas Securities LLC Acquires 456 Shares of Bio-Techne Co. (NASDAQ:TECH) - Defense World
TECH Gears Up to Report Q2 Earnings: Here's What to Expect - MSN
Bio-Techne (TECH) Projected to Post Earnings on Wednesday - MarketBeat
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Bio-Techne CEO Kim Kelderman sells $1.04 million in stock - MSN
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN
Bio-Techne CEO Kim Kelderman sells $1.04 million in stock By Investing.com - Investing.com South Africa
(TECH)Analyzing Bio-Techne's Short Interest - Benzinga
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
GMP Cell Therapy Consumables Market Top PlayersMiltenyi - openPR
First Citizens Bank & Trust Co. Buys 120,275 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
UMB Bank n.a. Buys 168 Shares of Bio-Techne Co. (NASDAQ:TECH) - Defense World
Bio-Techne (TECH) Stock Price, News & Analysis - MarketBeat
Bio-Techne (NASDAQ:TECH) Stock Price Down 4.5%Here's What Happened - MarketBeat
Spatial Proteomics Market Report and Competitive Landscape 2025-2030, with 10X Genomics, Bruker, Fluidigm, Akoya Biosciences, PerkinElmer, Biotechne, S2 Genomics, Seven Bridges Genomics & More - GlobeNewswire Inc.
Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Riverbridge Partners LLC Has $49.47 Million Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Fort Washington Investment Advisors Inc. OH Boosts Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Park Avenue Securities LLC Trims Holdings in Bio-Techne Co. (NASDAQ:TECH) - Defense World
Assenagon Asset Management S.A. Has $3.12 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Holdings Lifted by Assenagon Asset Management S.A. - Defense World
Bio-Techne Co. (NASDAQ:TECH) Receives $82.00 Consensus Target Price from Brokerages - Defense World
ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio - Yahoo Finance
Bio-Techne Earnings Preview: What to Expect - Nasdaq
Bio-Techne Sets Q2 2025 Earnings Call for February 5: Key Financial Updates Coming - StockTitan
Bio-Techne Earnings Preview: What To Expect - Barchart
바이오-테크네 (TECH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.82%
0.53%
자본화:
|
볼륨(24시간):